Propella: Intramuscular abiraterone decanoate for metastatic prostate cancer PRL-02

Clinical Trial Grant

Duke Scholars

Principal Investigator Michael Roger Harrison Medicine, Medical Oncology

Awarded By

Propella Therapeutics Inc

Start Date

January 20, 2022

End Date

September 26, 2026

Awarded By

Propella Therapeutics Inc

Start Date

January 20, 2022

End Date

September 26, 2026